ProVIDE II Bridging Study
NCT: NCT06236802 · ACTIVE_NOT_RECRUITING
NCT IDNCT06236802
StatusACTIVE_NOT_RECRUITING
Start Date2024-03-06
Completion2029-06-01
SponsorProVerum Medical (INDUSTRY)
First posted
Last updated
Brief Summary
The purpose of the ProVIDE II Bridging Study is to evaluate the performance of the Generation II delivery system when deploying the ProVee expander in subjects with symptomatic urinary obstruction secondary to BPH.
Frequently Asked Questions
What is ProVIDE II Bridging Study?
ProVIDE II Bridging Study is a clinical trial registered under NCT06236802. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT06236802?
The current status of NCT06236802 (ProVIDE II Bridging Study) is: ACTIVE_NOT_RECRUITING.
When did ProVIDE II Bridging Study start?
ProVIDE II Bridging Study started on 2024-03-06.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.